NIVF
NewGenIVF Group·NASDAQ
--
--(--)
--
--(--)
NIVF fundamentals
During Q3 2025, NewGenIVF Group (NIVF) reported revenue of 1.28M, a YoY change of -12.94%. Net income was 16.75M, a YoY change of 55297.35%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q3,2024 | Q4,2024 | Q3,2025 | TTM |
|---|
Start Date | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jul 1, 2024 | Oct 1, 2024 | Jul 1, 2025 | -- |
End Date | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Sep 30, 2024 | Dec 31, 2024 | Sep 30, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | -- -- | 4.12M -- | -- -- | -- -- | -- -- | 5.94M +44.34% | -- -- | -- -- | -- -- | 5.14M -13.59% | 1.47M -- | -- -- | 1.28M -12.94% | -- -- |
Sales and Services Revenue | -- -- | 4.12M -- | -- -- | -- -- | -- -- | 5.94M +44.34% | -- -- | -- -- | -- -- | 5.14M -13.59% | 1.47M -- | 1.27M -75.20% | 1.28M -12.94% | -- -- |
Cost of Revenue | -- -- | 3.09M -- | -- -- | -- -- | -- -- | 4.41M +42.45% | -- -- | -- -- | -- -- | 3.45M -21.61% | 824.03K -- | -- -- | 1.16M +41.28% | -- -- |
Cost of Goods and Services | -- -- | 3.09M -- | -- -- | -- -- | -- -- | 4.41M +42.45% | -- -- | -- -- | -- -- | 3.45M -21.61% | 824.03K -- | 734.48K -78.74% | 1.16M +41.28% | -- -- |
Gross Profit | -- -- | 1.02M -- | -- -- | -- -- | -- -- | 1.54M +50.06% | -- -- | -- -- | -- -- | 1.68M +9.37% | 648.83K -- | 539.13K -67.94% | 118.02K -81.81% | -- -- |
Operating Expenses | 80 -- | 823.93K -- | 160.03K -- | 122.69K -- | 106.55K +133088.75% | 749.79K -9.00% | 510.55K +219.03% | 367.00K +199.13% | 377.72K +254.49% | 384.28K -48.75% | 432.52K +14.51% | 1.63M +323.71% | 2.63M +508.19% | -- -- |
Selling, General and Administrative Expenses | 80 -- | 823.93K -- | 160.03K -- | 122.69K -- | 106.55K +133088.75% | 749.79K -9.00% | 510.55K +219.03% | 367.00K +199.13% | 377.72K +254.49% | 384.28K -48.75% | 432.52K +14.51% | 1.63M +323.71% | 2.63M +508.19% | -- -- |
Selling and Marketing Expenses | -- -- | 24.69K -- | -- -- | -- -- | -- -- | 36.19K +46.58% | -- -- | -- -- | -- -- | 18.03K -50.19% | 135.54K -- | 14.04K -22.14% | 187.21K +38.12% | -- -- |
General and Administrative Expenses | -- -- | 801.33K -- | -- -- | -- -- | -- -- | 1.10M +37.63% | -- -- | -- -- | -- -- | 1.62M +47.03% | 296.97K -- | 1.61M -0.45% | 2.44M +722.74% | -- -- |
Other Operating Expenses | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Income | -80 -- | 200.85K -- | -160.03K -- | -122.69K -- | -106.55K -133088.75% | 787.97K +292.32% | -510.55K -219.03% | -367.00K -199.13% | -377.72K -254.49% | 1.30M +64.66% | 216.31K +157.27% | -1.09M -183.94% | -2.51M -1261.52% | -- -- |
Non-Operating Income (Loss) | 0 -- | -42.57K -- | 6.53K -- | 94.15K -- | 314.87K -- | -470.27K -1004.60% | 562.67K +8515.33% | 452.50K +380.60% | 504.74K +60.30% | -1.45M -209.12% | -246.65K -148.87% | 546.44K +137.59% | 19.26M +7908.73% | -- -- |
Other Non-Operating Income (Loss) | -- -- | 45.65K -- | -- -- | -- -- | -- -- | 23.02K -49.58% | -- -- | -- -- | -- -- | 111.84K +385.85% | 1.26K -- | 962.99K +761.06% | 19.31M +1534729.65% | -- -- |
Net Interest Expense | 0 -- | 88.23K -- | -6.53K -- | -94.15K -- | -314.87K -- | 493.29K +459.12% | -562.67K -8515.33% | -452.50K -380.60% | -504.74K -60.30% | 1.57M +217.37% | 247.91K +149.12% | 416.55K -73.39% | 47.69K -80.77% | -- -- |
Interest Expense | -- -- | 88.29K -- | -- -- | -- -- | -- -- | 77.76K -11.93% | -- -- | -- -- | -- -- | 46.18K -40.61% | 237.39K -- | 421.11K +811.90% | 48.09K -79.74% | -- -- |
Interest Income | -- -- | 63 -- | 6.53K -- | 94.15K -- | 314.87K -- | -415.54K -659680.95% | 562.67K +8515.33% | 452.50K +380.60% | 504.74K +60.30% | -1.52M -265.64% | -10.52K -102.08% | 4.55K +100.30% | 409 +103.89% | -- -- |
Pretax Income From Continuing Operations | -80 -- | 158.27K -- | -153.50K -- | -28.54K -- | 208.32K +260503.75% | 317.70K +100.73% | 52.12K +133.95% | 85.50K +399.61% | 127.02K -39.03% | -156.22K -149.17% | -30.34K -123.89% | -- -- | 16.75M +55297.35% | -- -- |
Income Tax Expense | -- -- | 294.72K -- | -- -- | -- -- | -- -- | 208.14K -29.38% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -80 -- | -136.44K -- | -153.50K -- | -28.54K -- | 208.32K +260503.75% | 109.56K +180.30% | 52.12K +133.95% | 85.50K +399.61% | 127.02K -39.03% | -156.22K -242.59% | -30.34K -123.89% | -- -- | 16.75M +55297.35% | -- -- |
Net Income Attributable to Minority Interests | -- -- | -138.00K -- | -- -- | -- -- | -- -- | -322.82K -133.93% | -- -- | -- -- | -- -- | -21.77K +93.25% | -10.48K -- | 52.27K +340.02% | -75.37K -618.87% | -- -- |
Net Income Attributable to Owners of the Company | -80 -- | 1.56K -- | -153.50K -- | -28.54K -- | 208.32K +260503.75% | 432.38K +27670.01% | 52.12K +133.95% | 85.50K +399.61% | 127.02K -39.03% | -134.44K -131.09% | -19.86K -115.63% | -108.24K +19.49% | 16.82M +84822.54% | -- -- |
Net Income Attributable to Common Stockholders | -80 -- | 1.56K -- | -153.50K -- | -28.54K -- | 208.32K +260503.75% | 432.38K +27670.01% | 52.12K +133.95% | 85.50K +399.61% | 127.02K -39.03% | -134.44K -131.09% | -19.86K -115.63% | -108.24K +19.49% | 16.82M +84822.54% | -- -- |
Other Comprehensive Income | -- -- | 7.75K -- | -- -- | -- -- | -- -- | -1.92K -124.77% | -- -- | -- -- | -- -- | -22.70K -1082.50% | -256.36K -- | -- -- | -303.40K -18.35% | -- -- |
Total Comprehensive Income | -- -- | -130.78K -- | -- -- | -- -- | -- -- | 133.93K +202.41% | -- -- | -- -- | -- -- | 85.71K -36.00% | -286.70K -- | -- -- | 16.44M +5835.84% | -- -- |
Total Comprehensive Income Attributable to Minority Interests | -- -- | -136.40K -- | -- -- | -- -- | -- -- | -323.46K -137.15% | -- -- | -- -- | -- -- | -27.62K +91.46% | -76.95K -- | 55.41K +300.61% | -149.12K -93.79% | -- -- |
Total Comprehensive Income Attributable to Owners of the Company | -- -- | 5.62K -- | -- -- | -- -- | -- -- | 457.38K +8045.77% | -- -- | -- -- | -- -- | 113.33K -75.22% | -209.75K -- | -92.74K -181.83% | 16.59M +8011.11% | -- -- |
Basic EPS | 0 -- | -- -- | -0.23 -- | -0.35 -- | -0.33 -- | 0.05 -- | -0.58 -152.17% | -0.12 +65.71% | -0.12 +63.64% | -0.26 -620.00% | 0 +100.00% | -- -- | 7.82 -- | -- -- |
Diluted EPS | 0 -- | -- -- | -0.23 -- | -0.35 -- | -0.33 -- | -- -- | -0.58 -152.17% | -0.12 +65.71% | -0.12 +63.64% | -- -- | -- -- | -- -- | -- -- | -- -- |
You can ask Aime
What is NewGenIVF Group's latest dividend and current dividend yield?What is the market's earnings forecast for NewGenIVF Group next quarter?What does NewGenIVF Group do and what are its main business segments?What is the revenue and EPS growth rate for NewGenIVF Group year over year?What were the key takeaways from NewGenIVF Group's earnings call?What is NewGenIVF Group's gross profit margin?Did NewGenIVF Group beat or miss consensus estimates last quarter?What guidance did NewGenIVF Group's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
